Vous êtes ici

Prise en charge globale des toxidermies

Annales de Dermatologie et de Vénéréologie, Volume 134, Issue 4, April 2007, Pages 391 - 401

Références

  • 1. Barbaud A. Toxidermies immunoallergiques chez l’immunocompétent. Encyclopédie médicochirurgicale, 2004, 98-478-A-10:1-7.
  • 2. A. Barbaud. Démarche diagnostique devant une toxidermie. Concours Médical. 2003;125:1259-1266
  • 3. V. Djien, H. Bocquet, A. Dupuy, J. Revuz, J.C. Roujeau. Symptomatologie et marqueurs de sévérité des toxidermies érythémateuses. Ann Dermatol Venereol. 1999;126:247-250
  • 4. P.D. Ghislain, J.C. Roujeau. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J. 2002;8:5
  • 5. E. Silverman, K.H. In, C. Yandava, M. Drazen. Pharmacogenetics of the 5-lipoxygenase pathway in asthma. Clin Exp Allergy. 1998;28:164s-170s
  • 6. M. Viola, D. Quaratino, F. Gaeta, M. Caringi, R. Valluzzi, C. Caruso, et al. Celecoxib tolerability in patients with hypersensitivity (mainly cutaneous reactions) to nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol. 2005;137:145-150 Crossref
  • 7. K.K. Warner, J.A. Visconti, M.M. Tschampel. Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema. Ann Pharmacother. 2000;34:526-528
  • 8. D. Sondhi, M. Lippmann, G. Murali. Airway compromise due to angiotensin-converting enzyme inhibitor-induced angioedema: clinical experience at a large community teaching hospital. Chest. 2004;126:400-404 Crossref
  • 9. E.W. Van Rijnsoever, W.J. Kwee-Zuiderwijk, J. Fenestra. Angioneurotic edema attributed to the use of losartan. Arch Intern Med. 1998;158:2063-2065 Crossref
  • 10. S. Fays, P. Trechot, J.L. Schmutz, J.F. Cuny, F. Truchetet, A. Barbaud. Bupropion and generalized acute urticaria: eight cases. Br J Dermatol. 2003;148:171-172
  • 11. M.L. Chandeclerc, S. Martin, N. Petitpain, A. Barbaud, J.L. Schmutz. Tadalafil and palpebral edema. South Med J. 2004;97:1142-1143 Crossref
  • 12. F. Cousin, A. Catelain, K. Philips, B. Favier, E. Queuille, J.F. Nicolas. L’hypersensibilité immédiate est rarement en cause dans les urticaires médicamenteuses. Ann Dermatol Venereol. 2003;130:321-324
  • 13. G. Balint, P. Gergely. Clinical immunotoxicity of antirheumatic drugs. Inflamm Res. 1996;45:s91-s95
  • 14. Y. Teraki, T. Shiohara. Fixed drug eruption as a localized and mildform of toxic epidermal necrolysis. Ann Dermatol Venereol. 2002;129:1s35
  • 15. K. Alanko. Topical provocation of fixed drug eruption: a study of 30 patients. Contact Dermatitis. 1994;31:25-27 Crossref
  • 16. I. Figarella, A. Barbaud, T. Lecompte, E. De Maistre, S. Reichert-Penetrat, J.L. Schmutz. Réaction cutanée d’hypersensibilité retardée avec polysensibilisation aux héparines et héparinoïdes. Ann Dermatol Venereol. 2001;128:25-30
  • 17. E. Hohenstein, D. Tsakiris, A.J. Bircher. Delayed-type hypersensitivity to the ultra-low-molecular-weight heparin fondaparinux. Contact Dermatitis. 2004;51:149-150
  • 18. D.J. Schissel, D. Singer, K. David-Bajar. Azithromycin eruption in infectious mononucleosis: a proposed mechanism of interaction. Cutis. 2000;65:163-166
  • 19. S. Martin, A. Barbaud, J.L. Schmutz, B. Gobert, G. Faure, M.C. Béné. Polyclonalité de la réponse lymphocytaire T dans les tests d’activation lymphocytaire médicamenteux. Ann Dermatol Venereol. 2000;127:268-272
  • 20. D. Mauri-Helweg, M. Zanni, E. Frei, F. Bettens, C. Brander, D. Mauri, et al. Cross-reactivity of T cell clones to beta-lactam antibiotics. J Immunol. 1996;157:1071-1079
  • 21. A. Barbaud, S. Reichert-Penetrat, P. Trechot, M.A. Jacquin-Petit, A. Ehlinger, V. Noirez, et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol. 1998;139:49-58 Crossref
  • 22. A. Barbaud, M.C. Bene, G. Faure, J.L. Schmutz. Tests cutanés dans l’exploration des toxidermies supposées de mécanisme immuno-allergique. Bull Acad Natle Med. 2000;184:47-63
  • 23. A. Barbaud, M. Goncalo, D. Bruynzeel, A. Bircher. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis. 2001;45:321-328 Crossref
  • 24. A. Romano, D. Quarantino, M. Di Fonso, G. Papa, A. Venuti, G. Gasbarrini. À diagnostic protocol for evaluating nonimmediate reactions to aminopenicillins. J Allergy Clin Immunol. 1999;103:1186-1190 Crossref
  • 25. C. Beylot, P. Bioulac, M.S. Doutre. Pustulose exanthématique aiguë généralisée (quatre cas). Ann Dermatol Venereol. 1980;107:37-48
  • 26. A. Sidoroff, S. Halevy, J.N. Bavinck, L. Vaillant, J.C. Roujeau. Acute generalized exanthematous pustulosis (AGEP). À clinical reaction pattern. J Cutan Pathol. 2001;28:113-119 Crossref
  • 27. J.C. Roujeau, P. Bioulac Sage, C. Bourseau, J.C. Guillaume, P. Bermard, C. Lok, et al. Acute generalized exanthematous pustulosis. Arch Dermatol. 1991;127:1333-1338 Crossref
  • 28. M. Britschgi, U.C. Steiner, S. Schmid, J.P.H. Depta, G. Senti, A. Bircher, et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest. 2001;107:1433-1441 Crossref
  • 29. P. Wolkenstein, O. Chosidow, M.L. Flechet, O. Robbiola, M. Paul, L. Dumé, et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis. 1996;35:234-236 Crossref
  • 30. A. Sparsa, V. Loustaud-Ratti, M. Mousset-Hovaere, P. de Vençay, V. Le Brun, E. Liozon, et al. Syndrome d’hypersensibilité médicamenteuse en pratique interniste : pièges diagnostique et thérapeutique. Huit observation. Rev Med Interne. 2000;21:1052-1059 Crossref
  • 31. N. Cordel, B. Lenormand, P. Courville, P. Lauret, P. Joly. Détection du réarrangement clonal du gène gamma du récepteur des cellules T par PCR-DGGE pour le diagnostic des érythrodermies. Ann Dermatol Venereol. 2001;128:220-223
  • 32. V. Descamps, A. Valance, C. Eldinger, A.M. Fillet, M. Grossin, B. Lebrun-Vignes, et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol. 2001;137:301-304
  • 33. K. Hashimoto, M. Yasukawa, M. Tohyama. Human herpesvirus 6 and drug allergy. Curr Opin Allergy Clin Immunol. 2003;3:255-260 Crossref
  • 34. B. Janela, V. Descamps, D. Picard, S. Rogez, M. D’Incan, P. Bernard, et al. Rôle des réactivations virales sur la réponse lymphocytaire T au cours du syndrome d’hypersensibilité médicamenteuse. Ann Dermatol Venereol. 2005;132:9s37
  • 35. Y. Kano, M. Inaoka, T. Shiohara. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol. 2004;140:183-188
  • 36. A. Barbaud. Drug patch testing in systemic cutaneous drug allergy. Toxicology. 2005;209:209-216 Crossref
  • 37. J.C. Roujeau. The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification. J Invest Dermatol. 1994;102:s28-s30
  • 38. J.C. Roujeau, J.P. Kelly, L. Naldi, B. Rzany, R.S. Stern, T. Anderson, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995;333:1600-1607
  • 39. H. Bergoend, A. Loffler, R. Amar, J. Maleville. Réactions cutanées apparues durant une prophylaxie de masse de la méningite cérébrospinale avec un sulfamide d’action retardée. À propos de 997 cas. Ann Dermatol Venereol. 1968;95:481-490
  • 40. A. Barbaud. Physiopathologie de l’érythème polymorphe. Ann Dermatol Venereol. 1998;125:799-805
  • 41. S. Bastuji-Garin, B. Rzany, R.S. Stern, N.H. Shear, L. Naldi, J.C. Roujeau. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome and erythema multiforme. Arch Dermatol. 1993;129:92-96 Crossref
  • 42. A. Auquier-Dunant, M. Mockenhaupt, L. Naldi, O. Correia, W. Schroder, J.C. Roujeau, SCAR study Group. Severe cutaneous adverse reactions. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002;138:1019-1024
  • 43. H. Assier, S. Bastuji-Garin, J. Revuz, J.C. Roujeau. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol. 1995;131:539-543 Crossref
  • 44. B. Côté, J. Wechsler, S. Bastuji-Garin, H. Assier, J. Revuz, J.C. Roujeau. Clinicopathologic correlation in erythema multiforme and Stevens-Johnson syndrome. Arch Dermatol. 1995;131:1268-1272
  • 45. S. Inachi, H. Mizutani, M. Shimizu. Epidermal apoptotic cell death in erythema multiforme and Stevens-Johnson syndrome. Arch Dermatol. 1997;133:845-849 Crossref
  • 46. C. Paul, P. Wolkenstein, H. Adle, J. Wechsler, H.J. Garchon, J. Revuz, J.C. Roujeau. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol. 1996;134:710-714 Crossref
  • 47. M. Hertl, H. Bohlen, F. Jugert, C. Boecker, R. Knaup, H.F. Merk. Predominance of epidermal CD8+ T lymphocytes in bullous cutaneous reactions caused by beta-lactam antibiotics. J Invest Dermatol. 1993;101:794-799
  • 48. K. Ito, H. Hara, T. Okada, H. Shimojima, H. Suzuki. Toxic epidermal necrolysis treated with low-dose intravenous immunoglobulin: immunohistochemical study of Fas and Fas-Ligand expression. Clin Exp Dermatol. 2004;29:679-680 Crossref
  • 49. P. Hausermann, T. Harr, A.J. Bircher. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome?. Contact Dermatitis. 2004;51:297-310 Crossref
  • 50. A. Barbaud, P. Trechot, S. Reichert-Penetrat, N. Commun, J.L. Schmutz. Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions. Contact Dermatitis. 2001;45:265-268 Crossref
  • 51. M. Kleinhans, L. Linzbach, S. Zedlitz, R. Kaufmann, W.H. Boehncke. Positive patch test reactions to celecoxib may be due to irritation and do not correlate with the results of oral provocation. Contact Dermatitis. 2002;47:100-102 Crossref
  • 52. A. Barbaud, A. Bursztejn, C. Vernassiere, J.L. Schmutz, P. Tréchot. Toxidermie à l’Aérius®: les patch tests avec la desloratadine induisent des faux positifs. Ann Dermatol Venereol. 2005;132:s71
  • 53. P. Demoly. Anaphylactic reactions-value of skin and provocation tests. Toxicology. 2005;209:221-223 Crossref
  • 54. C. Ponvert, L. Le Clainche, J. de Blic, M. Le Bourgeois, P. Scheinmann, J. Paupe. Allergy to beta-lactam antibiotics in children. Pediatrics. 1999;104:e45 Crossref
  • 55. A. Romano, R.M. Gueant-Rodriguez, M. Viola, R. Pettinato, J.L. Gueant. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann Intern Med. 2004;141:16-22 Crossref
  • 56. D. Messaad, P. Demoly. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med. 2004;140:1001-1006 Crossref
  • 57. J. Waton, P. Tréchot, J.F. Cuny, J.L. Schmutz, A. Barbaud. Valeur prédictive négative des tests cutanés dans l’exploration des toxidermies. Ann Dermatol Venereol. 2005;132:s79
  • 58. B.A. Baldo. Penicillins and cephalosporins as allergens-structural aspects of recognition and cross-reactions. Clin Exp Allergy. 1999;29:744-749 Crossref
  • 59. A. Romano, R.M. Gueant-Rodriguez, M. Viola, F. Gaeta, C. Caruso, J.L. Gueant. Cross-reactivity among drugs: clinical problems. Toxicology. 2005;209:169-179 Crossref
  • 60. E. Perez-Inestrosa, R. Suau, M.I. Montanez, R. Rodriguez, C. Mayorga, M.J. Torres, M. Blanca. Cephalosporin chemical reactivity and its immunological implications. Curr Opin Allergy Clin Immunol. 2005;5:323-330
  • 61. M. Blanca, J.A. Cornejo-Garcia, M.J. Torres, C. Mayorga. Specificities of B cell reactions to drugs. The penicillin model. Toxicology. 2005;209:181-184 Crossref
  • 62. A. Barbaud, P. Tréchot, F. Weber-Muller, G. Ulrich, N. Commun, J.L. Schmutz. Drug skin tests in cutaneous adverse drug reactions to pristinamycin: 29 cases with a study of cross-reactions between synergistins. Contact Dermatitis. 2004;50:22-26 Crossref
  • 63. C. Vernassiere, A. Barbaud, P.H. Tréchot, F. Weber-Muller, J.L. Schmutz. Systemic acyclovir reaction subsequent to acyclovir contact allergy: which systemic antiviral drug should then be used?. Contact Dermatitis. 2003;49:155-157 Crossref
  • 64. C. Cholez, P. Tréchot, J.L. Schmutz, G. Faure, M.C. Bene, A. Barbaud. Maculopapular rash induced by diltiazem: allergological investigations in four patients and cross reactions between calcium channel blockers. Allergy. 2003;58:1207-1209 Crossref

Footnotes

Service de Dermatologie, Hôpital Fournier, 36, quai de la Bataille, 54000 Nancy

Tirés à part : A. Barbaud, à l’adresse ci-dessus.